ALMKT:EPA
Mauna Kea Technologies SA
€ 0.094
arrow_upward
+1.73%(+0.0016) Siku 1
13 Nov, 14:00:36 GMT +1 · EUR
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya ALMKT...
Fungua
€ 0.09
Juu
€ 0.10
Chini
€ 0.09
Mtaji wa soko
18.80M
Wastani wa kiasi cha mauzo
elfu 541.14
Kiasi cha mauzo ya hisa
elfu 52.93
Uwiano wa bei ya hisa na mapato kwa kila hisa
0.80
Juu kwa wiki 52
€ 0.23
Chini kwa wiki 52
€ 0.07
EPS
€ 0.12
Hisa za wawekezaji
195.26M
Idadi ya wafanyakazi
56
Fungua
€ 0.09
Juu
€ 0.10
Chini
€ 0.09
Mtaji wa soko
18.80M
Wastani wa kiasi cha mauzo
elfu 541.14
Kiasi cha mauzo ya hisa
elfu 52.93
Uwiano wa bei ya hisa na mapato kwa kila hisa
0.80
Juu kwa wiki 52
€ 0.23
Chini kwa wiki 52
€ 0.07
EPS
€ 0.12
Hisa za wawekezaji
195.26M
Idadi ya wafanyakazi
56
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
ChartMill
·
dakika 11 zilizopita
S&P 500 Premarket Movers: Travelers, Palo Alto Networks Gain; Cisco, AMD Fall
Kitco
·
dakika 14 zilizopita
Nasdaq futures subdued as Nvidia upheaval roils AI trade
BigGo Finance
·
dakika 23 zilizopita
Michael Burry Doubles Down on Nasdaq-100 and Semiconductor ETF Shorts, Betting Nvidia's Influence Will Wane
Yahoo Finance
·
dakika 33 zilizopita
The S&P 500 Recently Experienced Its Worst Day Since 2025. Here's Why Investors Shouldn't Worry.
Wasifu
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Kuhusu Mauna Kea Technologies SA
Afisa Mkuu Mtendaji (CEO)Sacha Loiseau
Wafanyakazi56
Lilianzishwa2000
Makao makuu-
SektaHealth Care
Sekta-
Tovutimaunakeatech.com